Spyre Therapeutics Ownership | Who Owns Spyre Therapeutics?

Overview Forecast RevenueFinancials Chart

Spyre Therapeutics Ownership Summary

Spyre Therapeutics is owned by 42.02% institutional investors, and 57.98% retail investors. Fmr is the largest institutional shareholder, holding 16.82% of SYRE shares.

SYRE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Spyre Therapeutics	42.02%	-	57.98%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	7.62M	16.82%	$224.22M
Fairmount funds management	4.02M	8.87%	$118.17M
Rtw investments, lp	3.26M	7.19%	$95.83M
Perceptive advisors	2.87M	6.34%	$84.48M
Vr adviser	2.69M	5.93%	$78.98M
Blackrock funding, inc. /de	2.66M	5.88%	$78.32M
Vanguard group	2.52M	5.55%	$73.99M
Braidwell lp	2.19M	4.83%	$64.40M
Commodore capital lp	1.99M	4.39%	$58.47M
Paradigm biocapital advisors lp	1.27M	2.80%	$37.28M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Fairmount funds management	4.02M	9.58%	$118.17M
Vr adviser	2.69M	4.14%	$78.98M
Commodore capital lp	1.99M	3.65%	$58.47M
Affinity asset advisors	498.42K	2.00%	$14.66M
Braidwell lp	2.19M	1.83%	$64.40M
Perceptive advisors	2.87M	1.79%	$84.48M
Rtw investments, lp	3.26M	1.39%	$95.83M
Paradigm biocapital advisors lp	1.27M	1.26%	$37.28M
Ikarian capital	302.25K	1.24%	$8.89M
Highvista strategies	105.35K	1.07%	$3.10M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	2.66M	0.00%	2.66M
Paradigm biocapital advisors lp	1.27M	1.26%	1.27M
Assenagon asset management	1.14M	0.06%	1.14M
Vanguard group	2.52M	0.00%	604.35K
Janus henderson group	1.12M	0.02%	446.66K

Top Sellers

Holder	Shares	% Assets	Change
Avoro capital advisors	598.60K	0.26%	-1.24M
Deep track capital, lp	1.00M	0.93%	-756.67K
Farallon capital management	-	-	-666.00K
First turn management	-	-	-464.44K
Darwin global management	-	-	-452.04K

New Positions

Holder	Shares	% Assets	Change	Value
Blackrock funding, inc. /de	2.66M	0.00%	2.66M	$78.32M
Paradigm biocapital advisors lp	1.27M	1.26%	1.27M	$37.28M
Ikarian capital	302.25K	1.24%	302.25K	$8.89M
Emerald advisers	292.57K	0.33%	292.57K	$8.60M
Emerald mutual fund advisers trust	253.55K	0.39%	253.55K	$7.46M

Sold Out

Holder	Change
Point72 (difc)	-22.00
Pacer advisors	-382.00
Chartwell investment partners	-6.83K
Susquehanna fundamental investments	-8.07K
Polymer capital management (hk)	-10.52K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	55	-49.07%	19,042,524	-62.21%	42	0.34%	42	-44.00%	5	-70.59%
Mar 31, 2024	102	82.14%	31,642,952	12.97%	86	0.27%	74	68.18%	15	200.00%
Dec 31, 2023	56	93.10%	28,010,908	759.76%	179	3.12%	44	62.96%	5	-
Sep 30, 2023	29	-	3,257,983	-	75	-	27	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 06, 2024	Albers Jeffrey W.	-	Sell	$246.31K
Oct 25, 2024	Albers Jeffrey W.	-	Sell	$10.93K
Sep 03, 2024	Burrows Scott L	Chief Financial Officer	Sell	$522.07K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	2
2024 Q3	-	1
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

SYRE Ownership FAQ

Who Owns Spyre Therapeutics?

Spyre Therapeutics shareholders are primarily institutional investors at 42.02%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Spyre Therapeutics's industry, Biotech Stocks , is 47.04%, which Spyre Therapeutics falls below.

Who owns the most shares of Spyre Therapeutics?

Spyre Therapeutics’s largest shareholders are Fmr (7.62M shares, 16.82%), Fairmount funds management (4.02M shares, 8.87%), and Rtw investments, lp (3.26M shares, 7.19%). Together, they hold 32.88% of Spyre Therapeutics’s total shares outstanding.

Does Blackrock own Spyre Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Spyre Therapeutics.

Who is Spyre Therapeutics’s biggest shareholder by percentage of total assets invested?

Fairmount funds management is Spyre Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.58% of its assets in 4.02M Spyre Therapeutics shares, valued at 118.17M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools